Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C raises $27.4mm for Spinal Modulation

Executive Summary

Spinal device developer Spinal Modulation raised $27.4mm in its Series C financing led by first-time backer Johnson & Johnson Development Corp., which was joined by other new investors DFJ InCube Ventures and Raffles Venture Partners and returning shareholders De Novo Ventures, DFJ ePlanet Ventures, Kleiner Perkins Caufield & Byers, and MedVenture Associates.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies